Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9444 |
High Similarity |
NPD548 |
Clinical (unspecified phase) |
0.9091 |
High Similarity |
NPD1776 |
Approved |
0.9091 |
High Similarity |
NPD1777 |
Approved |
0.9007 |
High Similarity |
NPD2624 |
Phase 2 |
0.8933 |
High Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.8808 |
High Similarity |
NPD1369 |
Phase 2 |
0.8758 |
High Similarity |
NPD1732 |
Phase 3 |
0.8758 |
High Similarity |
NPD2646 |
Discontinued |
0.8523 |
High Similarity |
NPD250 |
Approved |
0.8523 |
High Similarity |
NPD249 |
Approved |
0.8442 |
Intermediate Similarity |
NPD3107 |
Discontinued |
0.8411 |
Intermediate Similarity |
NPD195 |
Approved |
0.8411 |
Intermediate Similarity |
NPD186 |
Discovery |
0.8389 |
Intermediate Similarity |
NPD185 |
Approved |
0.8303 |
Intermediate Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.8294 |
Intermediate Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.8294 |
Intermediate Similarity |
NPD2632 |
Approved |
0.8294 |
Intermediate Similarity |
NPD2630 |
Approved |
0.8278 |
Intermediate Similarity |
NPD166 |
Approved |
0.8255 |
Intermediate Similarity |
NPD193 |
Suspended |
0.8194 |
Intermediate Similarity |
NPD283 |
Approved |
0.8153 |
Intermediate Similarity |
NPD339 |
Approved |
0.8138 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.8089 |
Intermediate Similarity |
NPD338 |
Approved |
0.8089 |
Intermediate Similarity |
NPD242 |
Approved |
0.7987 |
Intermediate Similarity |
NPD169 |
Phase 2 |
0.7965 |
Intermediate Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.7751 |
Intermediate Similarity |
NPD5666 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD214 |
Approved |
0.775 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD220 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD219 |
Phase 3 |
0.7716 |
Intermediate Similarity |
NPD216 |
Approved |
0.7716 |
Intermediate Similarity |
NPD218 |
Approved |
0.7716 |
Intermediate Similarity |
NPD217 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7988 |
Suspended |
0.7647 |
Intermediate Similarity |
NPD4495 |
Phase 1 |
0.7607 |
Intermediate Similarity |
NPD546 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD4716 |
Approved |
0.7453 |
Intermediate Similarity |
NPD3708 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD3083 |
Approved |
0.7396 |
Intermediate Similarity |
NPD247 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7158 |
Phase 1 |
0.7345 |
Intermediate Similarity |
NPD1692 |
Approved |
0.7263 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.7263 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD516 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD7138 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD9632 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD252 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD194 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD549 |
Approved |
0.7039 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD582 |
Approved |
0.6946 |
Remote Similarity |
NPD231 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1058 |
Discontinued |
0.6928 |
Remote Similarity |
NPD3085 |
Phase 1 |
0.6894 |
Remote Similarity |
NPD3695 |
Approved |
0.6894 |
Remote Similarity |
NPD3696 |
Approved |
0.6886 |
Remote Similarity |
NPD3086 |
Phase 3 |
0.6865 |
Remote Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6811 |
Remote Similarity |
NPD207 |
Discontinued |
0.6804 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6804 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6735 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.673 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6689 |
Remote Similarity |
NPD9606 |
Approved |
0.6647 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD1430 |
Approved |
0.6646 |
Remote Similarity |
NPD1431 |
Approved |
0.6645 |
Remote Similarity |
NPD9607 |
Approved |
0.6598 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.6598 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD4240 |
Approved |
0.6497 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.649 |
Remote Similarity |
NPD9374 |
Approved |
0.6488 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6467 |
Remote Similarity |
NPD9373 |
Approved |
0.6433 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6429 |
Remote Similarity |
NPD307 |
Approved |
0.6429 |
Remote Similarity |
NPD171 |
Discontinued |
0.642 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.6385 |
Remote Similarity |
NPD5627 |
Approved |
0.6378 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.6369 |
Remote Similarity |
NPD798 |
Discontinued |
0.6368 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6355 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6355 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6348 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6341 |
Remote Similarity |
NPD1120 |
Approved |
0.6341 |
Remote Similarity |
NPD1121 |
Approved |
0.6335 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6316 |
Remote Similarity |
NPD775 |
Approved |
0.6306 |
Remote Similarity |
NPD5171 |
Clinical (unspecified phase) |
0.6296 |
Remote Similarity |
NPD282 |
Approved |
0.628 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6272 |
Remote Similarity |
NPD9704 |
Approved |
0.6264 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.6258 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.6232 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6231 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6216 |
Remote Similarity |
NPD8836 |
Approved |
0.6207 |
Remote Similarity |
NPD353 |
Discontinued |
0.6184 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6178 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.6175 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6169 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.6168 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6167 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.6159 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.6154 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6139 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6133 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.6114 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD1127 |
Approved |
0.6111 |
Remote Similarity |
NPD1128 |
Approved |
0.6095 |
Remote Similarity |
NPD1118 |
Discontinued |
0.609 |
Remote Similarity |
NPD8831 |
Approved |
0.609 |
Remote Similarity |
NPD8833 |
Approved |
0.6087 |
Remote Similarity |
NPD281 |
Approved |
0.6038 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.6012 |
Remote Similarity |
NPD6112 |
Approved |
0.5975 |
Remote Similarity |
NPD9409 |
Discontinued |
0.5974 |
Remote Similarity |
NPD9375 |
Discontinued |
0.593 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5903 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.5882 |
Remote Similarity |
NPD6840 |
Approved |
0.587 |
Remote Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.5869 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.5858 |
Remote Similarity |
NPD535 |
Approved |
0.5854 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5849 |
Remote Similarity |
NPD9360 |
Approved |
0.5825 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5825 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5818 |
Remote Similarity |
NPD1356 |
Approved |
0.5818 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.5818 |
Remote Similarity |
NPD1354 |
Approved |
0.5805 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.5804 |
Remote Similarity |
NPD5172 |
Phase 2 |
0.5802 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.5801 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.5798 |
Remote Similarity |
NPD6023 |
Discontinued |
0.5789 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.5786 |
Remote Similarity |
NPD1368 |
Approved |
0.5765 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.5759 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5741 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.5735 |
Remote Similarity |
NPD4599 |
Clinical (unspecified phase) |
0.5733 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.5728 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.5728 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.5728 |
Remote Similarity |
NPD4714 |
Approved |
0.5728 |
Remote Similarity |
NPD34 |
Approved |
0.5724 |
Remote Similarity |
NPD341 |
Approved |
0.5724 |
Remote Similarity |
NPD340 |
Approved |
0.5722 |
Remote Similarity |
NPD3593 |
Approved |
0.5721 |
Remote Similarity |
NPD796 |
Phase 2 |
0.5707 |
Remote Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.5685 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5685 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.5676 |
Remote Similarity |
NPD5935 |
Discontinued |
0.5663 |
Remote Similarity |
NPD1085 |
Approved |
0.5663 |
Remote Similarity |
NPD1775 |
Approved |
0.5654 |
Remote Similarity |
NPD4089 |
Clinical (unspecified phase) |
0.5652 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.5636 |
Remote Similarity |
NPD9544 |
Approved |
0.5636 |
Remote Similarity |
NPD78 |
Approved |
0.5636 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.5602
|
Remote Similarity |
NPD4812 |
Phase 1 |